People who are new to telehealth peptide therapy almost always have the same underlying question: what actually happens between deciding to look into this and a medication arriving at the door? The answer matters, because the journey is the medicine in many ways. A program that takes intake, labs, and clinician review seriously produces a different experience — and different outcomes — than one that does not.
This article walks the full journey end to end, with realistic timelines and what to expect at each step.
Step 1: Initial sign-up and digital intake (Day 0 to 2)
The first step is a structured online intake. A serious platform asks about much more than your goals.
A complete intake covers:
- Demographics and current address (used for clinician licensure matching)
- Height, weight, and body composition history
- Detailed medical history: chronic conditions, prior diagnoses, hospitalizations
- Surgical history
- Current medications and supplements, including dose and duration
- Allergies, including injection-site sensitivities
- Family history relevant to specific peptide contraindications (for example, medullary thyroid carcinoma or MEN2 for GLP-1 candidates)
- Pregnancy status, breastfeeding status, and contraception (if applicable)
- Mental health history including eating disorder history
- Substance use history
- Goals and prior attempts (diet history, weight cycling, prior medications)
A common shortcut among less-rigorous platforms is to ask only the goal question and a handful of contraindication checkboxes. That speeds onboarding but tells the clinician very little. The thoroughness of the intake is one of the strongest predictors of whether you are entering a clinical relationship or a transactional one.
Time investment: 15 to 30 minutes, asynchronous.
Step 2: Lab review or lab scheduling (Day 2 to 7)
Once intake is complete, the clinical team reviews your history and decides on labs.
If you have recent, comprehensive labs from an accredited laboratory, you can upload them during intake. Most clinicians will accept labs drawn within the past 90 to 180 days, depending on the panel and your history. This can shorten the timeline considerably.
If you do not, the platform schedules new draws, typically through a national laboratory network with thousands of patient service centers. The exact panel depends on the therapy under consideration, but a reasonable baseline for metabolic peptide candidates includes:
- Comprehensive metabolic panel (CMP)
- Lipid panel
- Hemoglobin A1c
- Fasting insulin (often)
- Thyroid panel (TSH, sometimes free T4 and free T3)
- Complete blood count (CBC)
- IGF-1 if hormone optimization is also being considered
- Gonadal hormones for relevant patients
You drive to a lab, fast if required, get a quick blood draw, and results typically post within 2 to 5 business days.
What this step is really doing: it is setting the baseline against which therapy will be judged. Without a baseline, no one — not you, not the clinician — has any objective basis to know whether the medication is helping you, hurting you, or doing nothing. A program that prescribes without labs is making a decision blind, and it is making it on your behalf.
Step 3: Clinician video evaluation (Day 5 to 10)
With intake and labs complete, you book a video visit with a clinician licensed in your state. This is the visit that legally and clinically establishes the prescriber-patient relationship in most states.
A good first visit covers:
- Review of your history in your own words
- Discussion of labs, what they show, and what they imply
- Explicit discussion of your goals and what is realistic
- Review of relevant contraindications
- Treatment options, including non-pharmacologic alternatives
- Specific recommendation: which molecule, what dose, what schedule, why
- Side effects, what to watch for, what to do
- Cost and logistics
- Follow-up plan
A typical first visit runs 20 to 40 minutes. If a platform offers a 5-minute "consultation," that is not really a consultation — it is a checkbox. Real medical decision-making does not happen in 5 minutes.
Some platforms layer asynchronous secure messaging on top of synchronous visits, so questions you think of after the call can be answered without scheduling a new appointment. That continuity is a meaningful quality signal.
Step 4: Prescription decision (Day 10 to 12)
After the visit, the clinician makes a prescribing decision. Three possible outcomes:
-
Proceed with prescription. The clinician writes a specific order — molecule, dose, titration schedule, refill plan — and sends it to the dispensing pharmacy.
-
Conditional proceed. The clinician identifies something that needs follow-up before prescribing — a specific lab, a specialist consult, a medication interaction to address — and outlines what is needed to move forward.
-
Decline to prescribe. Some patients are not candidates. Either the clinical picture contraindicates therapy, the goal is not appropriately served by the proposed therapy, or a different intervention is more appropriate. In these cases you should not be charged for medication, and you should leave the encounter with a clear explanation and ideally a referral or alternative path.
Outcome 3 is uncommon but extremely important. A program that prescribes to everyone is a program that is not really evaluating anyone.
Step 5: Pharmacy fulfillment and shipment (Day 10 to 14)
Once the prescription is written, it routes to a state-licensed pharmacy authorized to ship to your address. Two paths:
- Brand FDA-approved product: dispensed from a regular retail or specialty pharmacy. This is straightforward when the medication is in stock and your insurance or cash pay is set up.
- Compounded preparation: prepared by a 503A or 503B compounding pharmacy. Because compounded preparations are made patient-specific, there is a small additional preparation window — typically a few business days — before shipment.
Shipments are typically sent with cold-chain packaging if the medication requires refrigeration, with tracked delivery and signature on receipt. You should be able to see exactly which pharmacy is shipping your medication and verify its licensure if you wish.
Time from prescription to delivery: typically 3 to 7 business days.
Step 6: First dose preparation and onboarding (Day 12 to 14)
Receiving the package is not the same as starting the medication. Before the first dose, a quality program provides:
- Written and (often) video instructions specific to your medication
- Storage instructions: refrigeration requirements, expiration timeline after first use
- Injection technique walkthrough for subcutaneous medications
- Site rotation guidance to avoid lipohypertrophy
- A clearly labeled dose schedule
- An emergency contact pathway for unexpected reactions
Some patients schedule a brief video onboarding with a nurse or clinician for the first dose, especially if they are new to self-injection. This is not necessary for everyone but is offered by many high-quality platforms.
Step 7: First dose (Week 2 to 3)
The first dose is typically taken at home, at a deliberately chosen time (often early evening for once-weekly subcutaneous injections, so any first-day nausea passes during sleep). For GLP-1 medications, most patients notice subtle appetite reduction within 24 to 72 hours; some notice nothing for a week. For hormone axis peptides, subjective effects build over weeks and lab markers shift over the first 4 to 8 weeks.
What you should not feel: severe symptoms, rapid heart rate, severe pain at the injection site, allergic reactions, or significant gastrointestinal distress. If any of these occur, the platform should give you a defined pathway to reach a clinician quickly.
Step 8: Early follow-up (Week 2 to 8)
The first follow-up window is the most important. Common cadence:
- A check-in within the first 7 to 14 days, often by message
- A scheduled video follow-up at 4 weeks
- A second video follow-up at 8 weeks
- Re-check labs at 8 to 12 weeks depending on therapy
This is when the plan adjusts. Side effects get addressed. Dose changes happen. Lifestyle inputs (protein, training, sleep) are revisited. The patient is in dialogue with the clinician about what is working and what is not.
Step 9: Maintenance, reassessment, and the long arc (Month 3+)
Beyond the first quarter, peptide therapy becomes a longitudinal relationship. You are checking in periodically, refreshing labs at clinician-defined intervals, and adjusting as the body and goals evolve. This is the phase where most of the actual clinical value lives. The dramatic stories happen in the first few weeks; the durable outcomes happen over the months and years.
Some patients move from a weight-loss-oriented protocol to a maintenance microdose. Some patients add a second therapy aimed at recomposition or hormone optimization. Some taper off entirely. The plan is not pre-determined; it follows the data.
Realistic timeline summary
| Phase | Typical timing |
|---|---|
| Intake | Day 0 to 2 |
| Lab scheduling and draws | Day 2 to 7 |
| Lab results returned | Day 5 to 10 |
| Clinician video visit | Day 5 to 10 |
| Prescription decision | Day 10 to 12 |
| Pharmacy fulfillment and shipment | Day 10 to 14 |
| First dose | Day 12 to 17 |
| First follow-up | Day 19 to 28 |
| First lab re-check | Week 8 to 12 |
A patient who already has recent comprehensive labs and is a clear candidate may move faster. A patient with complex history, missing data, or contraindications that need workup will move more slowly — appropriately.
What good looks like, and what to avoid
A high-quality patient journey shares the same fingerprints across platforms:
- Thorough intake that takes meaningful time to complete
- Real labs reviewed by a real clinician
- A licensed clinician evaluation in a synchronous visit (typically video)
- A specific, named prescription decision with a documented rationale
- A licensed pharmacy with verifiable credentials
- Defined follow-up cadence and clear emergency pathways
- Willingness to say no when a patient is not a candidate
Warning signs include same-day prescriptions with no labs, no clinician visit, no follow-up plan, an opaque dispensing pharmacy, or a platform that prescribes the same thing to everyone regardless of history. Telehealth done well is medicine. Telehealth done poorly is shipping logistics with a doctor''s name on the box.
Key takeaways
- The full journey from sign-up to first dose typically takes 7 to 14 days, with longer timelines for patients who need additional workup.
- A complete intake, real baseline labs, and a real clinician video visit are the load-bearing elements of the journey — not the medication itself.
- Some patients are not candidates, and a responsible platform will say so.
- The first follow-up window is where the plan adjusts and where ongoing therapy is shaped.
- Long-term outcomes are produced by the longitudinal relationship, not by the first shipment.
Patients evaluating telehealth peptide therapy should expect — and should ask for — a journey that takes them seriously at every step. The medication is the easy part. The clinical relationship around it is what makes the medication actually work.
FAQ
Common questions
How long does it take to go from signing up to first dose?
For most patients the full journey takes 7 to 14 days: a few days for intake and lab scheduling, a week or so for lab results to return, a same-week clinician review, and a few days for the pharmacy to compound or dispense and ship. Patients with prior recent labs may move faster.
What if I already have recent labs?
You can upload them during intake. If they were drawn within the last 90 to 180 days at an accredited lab and cover the required panels, your clinician can usually use them and skip a redraw, accelerating your journey.
Do I have to do a video visit?
In most cases yes. State licensure rules and good clinical practice both favor a synchronous video evaluation before the first prescription. A few states or visit types allow asynchronous review under specific conditions, but the default is video.
Can I be denied a prescription after I sign up?
Yes, and that is a feature, not a bug. If your history, labs, or clinical picture indicate that prescribed peptide therapy is not appropriate or not safe for you, the responsible answer is no — sometimes outright, sometimes pending additional workup. You should not be charged a medication fee in that case.
What does the first dose actually feel like?
For GLP-1 medications, most patients notice mild appetite reduction and possibly mild nausea within the first 24 to 72 hours. For hormone-axis peptides, subjective effects emerge over weeks. Your clinician walks you through what to expect and what would warrant a check-in.
What happens after the first dose?
You move into a structured follow-up cadence: a check-in within the first one to two weeks, scheduled visits at four to eight week intervals early on, and re-check labs at clinician-defined timepoints. Therapy is iterative — the plan adjusts based on your data.
Next Step
Talk to a TelePeptide Clinician
A licensed clinician will review your goals and recommend the right protocol — peptide wellness, recomposition, or supervised weight loss. No insurance, no waiting room.
TelePeptide offers direct-pay telehealth services. All medications are compounded by licensed 503A pharmacies. Prescribing decisions are made solely by licensed clinicians based on individual medical necessity. These statements have not been evaluated by the FDA. Compounded medications are not FDA-approved.